Medical News

RSS
Study: Use of antipsychotic medication during pregnancy can affect babies

Study: Use of antipsychotic medication during pregnancy can affect babies

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

Jazz Pharmaceuticals' JZP-110 improves symptoms of EDS in adults with narcolepsy

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

EHR solutions provider, ChartLogic, partners with Kareo

EHR solutions provider, ChartLogic, partners with Kareo

Cerenis’ SAMBA and MODE Phase II Studies Meet Primary Endpoints for Treatment of FPHA, HoFH

Cerenis’ SAMBA and MODE Phase II Studies Meet Primary Endpoints for Treatment of FPHA, HoFH

CRS-207 and chemotherapy combination Phase 1b trial data for unresectable MPM presented at ASCO 2014

CRS-207 and chemotherapy combination Phase 1b trial data for unresectable MPM presented at ASCO 2014

AMRI agrees to acquire OsoBio for $110 million

AMRI agrees to acquire OsoBio for $110 million

Alkermes initiates second ALKS 3831 Phase 2 clinical study for treatment of schizophrenia

Alkermes initiates second ALKS 3831 Phase 2 clinical study for treatment of schizophrenia

ProMark test for prostate cancer meets primary endpoint

ProMark test for prostate cancer meets primary endpoint

FDA grants OsteoSymbionics 510(k) clearance for sterile processing of ClearShield cranial implant product

FDA grants OsteoSymbionics 510(k) clearance for sterile processing of ClearShield cranial implant product

Endo International subsidiary sells pharmaceutical drug discovery platform to AsanaBioSciences

Endo International subsidiary sells pharmaceutical drug discovery platform to AsanaBioSciences

Ovarian cancer patients with molecular subtypes benefit from bevacizumab

Ovarian cancer patients with molecular subtypes benefit from bevacizumab

FDA approves Can-Fite's study protocol for CF102 Phase II clinical trial for advanced liver cancer

FDA approves Can-Fite's study protocol for CF102 Phase II clinical trial for advanced liver cancer

Physicians Interactive eCoupon now available within Greenway Health's PrimeSUITE EHR system

Physicians Interactive eCoupon now available within Greenway Health's PrimeSUITE EHR system

First Edition: June 2, 2014

First Edition: June 2, 2014

Yale researchers find that hormone leptin may help treat metabolic disorders

Yale researchers find that hormone leptin may help treat metabolic disorders

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

MESA, Curagita join forces to bring Diagnostic Imaging services to Germany

Cherokee Health Systems selects NextGen Healthcare to provide RCM services

Cherokee Health Systems selects NextGen Healthcare to provide RCM services

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

Nektar reports etirinotecan pegol Phase 2 study results in patients with Avastin-refractory high-grade glioma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.